COO (The Cooper) Total Long-Term Assets: $10,183 Mil (As of Apr. 2026)


COO The Cooper Companies Inc COO
84 GF Score
Price $69.76
GF Value $101.09
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is The Cooper Total Long-Term Assets?

The Cooper COO -2.96% 84 Total Long-Term Assets is $10,183 Mil as of Apr. 2026. GuruFocus rates COO with a GF Score™ of 84/100 and a GF Value™ of $101.09 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. The Cooper's Total Long-Term Assets for the quarter that ended in Apr. 2026 was $10,183 Mil.

The Cooper Total Long-Term Assets Historical Data

* Premium members only.

The historical data trend for The Cooper's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Cooper Total Long-Term Assets Chart

The Cooper Annual Data
Trend Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
Total Long-Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8,140.90 9,958.70 9,954.00 10,363.70 10,288.40

The Cooper Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Total Long-Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10,287.90 10,238.90 10,288.40 10,290.40 10,182.50
COO
84GF Score
The Cooper Companies Inc COO
Total Long-Term Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

The Cooper Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

Frequently Asked Questions Learn more about Total Long-Term Assets →
What does a Total Long-Term Assets of $10,183 Mil mean?
The Cooper (COO) has a Total Long-Term Assets of $10,183 Mil as of Apr. 2026. Total Long-Term Assets are assets that are expected to be realized in cash, sold or consumed longer than one year. View historical data on The Cooper and its competitors.
Is The Cooper's Total Long-Term Assets too high?
The Cooper's current Total Long-Term Assets is $10,183 Mil. Overall, The Cooper has a GF Score™ of 84/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Cooper's Total Long-Term Assets compare to SOLV and ALGN?
The Cooper's Total Long-Term Assets of $10,183 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Long-Term Assets for a Medical Devices & Instruments company?
A good Total Long-Term Assets depends on the Medical Devices & Instruments industry context. However, Total Long-Term Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Long-Term Assets mean?
A high Total Long-Term Assets can signal that a stock is expensive relative to its fundamentals. Total Long-Term Assets are assets that are expected to be realized in cash, sold or consumed longer than one year. View historical data on The Cooper and its competitors. The Cooper's current Total Long-Term Assets is $10,183 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Cooper stock overvalued right now?
Based on GuruFocus' analysis, The Cooper (COO) is currently considered Significantly Undervalued. The stock's GF Value™ is $101.09, compared to a current price of $69.76 — trading 31% below its estimated fair value. The current Total Long-Term Assets is $10,183 Mil. The Cooper's overall GF Score™ is 84/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Long-Term Assets calculated?
Total Long-Term Assets is calculated from a company's financial statements. For The Cooper (COO), the current Total Long-Term Assets is $10,183 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is The Cooper (COO) Overvalued in 2026?

Based on GuruFocus' analysis, The Cooper stock appears to be undervalued. The current stock price of $69.76 is trading 31% below its estimated GF Value™ of $101.09. GuruFocus considers The Cooper to be Significantly Undervalued.

Key valuation signals for COO:

  • Total Long-Term Assets: $10,183 Mil
  • GF Value™: $101.09 vs. price of $69.76 (31% below fair value)
  • GF Score™: 84/100 with 3 warning signs

No single metric tells the full story. See the COO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

The Cooper Business Description

Address 6101 Bollinger Canyon Road, Suite 500, San Ramon, CA, USA, 94583
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
84GF Score

Get the complete analysis for COO

Total Long-Term Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$69.76
Price
$101.09
GF Value